(3-{[(2R,3S)-2-{(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)-4-morpholinyl]methyl}-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid - 1-deoxy-1-(methylamino)-D-glucitol (1: 2)(CAS: 265121-04-8)

This compound is a complex phosphonic acid derivative with a glucitol moiety, featuring multiple chiral centers and functional groups such as trifluoromethyl, fluorophenyl, and morpholinyl. Its molecular structure includes a 1H-1,2,4-triazole ring, which is often associated with biological activity. The compound is known for its potential in pharmaceutical applications due to its intricate chemical framework.

This compound is primarily used in pharmaceutical research, particularly in the development of drugs targeting metabolic disorders and diabetes. Its unique structure allows for interactions with glucose transporters, making it a candidate for therapeutic applications. It may also find use in chemical synthesis and as a research reagent in biochemistry and medicinal chemistry.

Safety data for this compound is limited, but it is generally considered to have low acute toxicity based on preliminary studies. Handling should be done with appropriate protective equipment, and it is advisable to follow standard laboratory safety protocols. Long-term health effects and environmental impact require further research to ensure safe usage.

This compound should be stored in a cool, dry, and dark place, ideally at 2-8°C, in a sealed container to prevent moisture absorption. It is sensitive to light and humidity, so storage in airtight, light-resistant containers is recommended. Avoid exposure to air and keep away from incompatible substances to maintain stability and purity.